1 results match your criteria: "and University College London Hospitals and Cancer Institute[Affiliation]"
Combined inhibition of BRAF and MEK in melanoma patients.
Lancet Oncol
August 2014
Cancer Research UK London Research Institute, and University College London Hospitals and Cancer Institute, London, UK.